Triple therapy helped type 1 patients improve glycemia
NEW ORLEANS – The addition of dapagliflozin to insulin and liraglutide in patients with type 1 diabetes resulted in a significant improvement in glycemia, results from a single-center randomized... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - July 13, 2016 Category: Endocrinology Source Type: news
Liraglutide reduces blood sugars in patients taking large amounts of insulin
A new drug called Liraglutide has several effects on the body: It increases insulin secretion; it reduces hunger; and it decreases glucagon secretion. Insulin and glucagon are molecules produced by the pancreas that have opposing effects, with insulin reducing blood sugar levels and glucagon increasing blood sugar levels. Insulin is secreted by beta cells in the pancreas and glucagon is secreted by alpha cells in the pancreas. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 6, 2016 Category: Science Source Type: news
Are Expensive Diabetes Drugs Worth It?
(MedPage Today) -- Jardiance and Victoza improve hard outcomes, but at a hefty cost (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 23, 2016 Category: American Health Source Type: news
LEADER: Liraglutide lowers CVD risk in type 2 diabetes
Liraglutide is associated with a decreased risk of cardiovascular events, compared with placebo, in individuals with type 2 diabetes, according to results from the randomized, placebo-controlled,... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - June 22, 2016 Category: Endocrinology Source Type: news
Two Weight-Loss Drugs Have Highest Odds for 5% ReductionTwo Weight-Loss Drugs Have Highest Odds for 5% Reduction
Phentermine-topiramate and liraglutide were most likely among five obesity drugs approved by the FDA for long-term use to help people achieve a 5% weight loss over a year, a meta-analysis shows. Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 15, 2016 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Diabetes Drug Victoza May Help the Heart: Study
Title: Diabetes Drug Victoza May Help the Heart: StudyCategory: Health NewsCreated: 6/14/2016 12:00:00 AMLast Editorial Review: 6/15/2016 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - June 15, 2016 Category: Endocrinology Source Type: news
5 weight loss drugs that actually work in the US
Scientists at the University of California found of the drugs - orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and liraglutide - the last two, marketed as Qsymia, Saxenda and Victoza were most effective. (Source: the Mail online | Health)
Source: the Mail online | Health - June 15, 2016 Category: Consumer Health News Source Type: news
Diabetes Drug Victoza May Help the Heart: Study
Daily, injected medication shows 'encouraging' results in international trial (Source: WebMD Health)
Source: WebMD Health - June 14, 2016 Category: Consumer Health News Source Type: news
Liraglutide cardioprotective in high-risk Type 2 diabetes patients
Findings of the LEADER trial show that liraglutide treatment may confer a reduced risk of cardiovascular events in patients with Type 2 diabetes and a high vascular risk. (Source: MedWire News)
Source: MedWire News - June 14, 2016 Category: Consumer Health News Tags: Diabetes Source Type: news
Revealed... the 5 weight loss drugs that ACTUALLY work - helping obese people shed up to 20lbs in a year
Scientists at the University of California found of the drugs - orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and liraglutide - the last two, marketed as Qsymia, Saxenda and Victoza were most effective. (Source: the Mail online | Health)
Source: the Mail online | Health - June 14, 2016 Category: Consumer Health News Source Type: news
Study compares effectiveness of weight-loss drugs
In an analysis that included nearly 30,000 overweight or obese adults, compared with placebo, orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and liraglutide were each associated with achieving at least 5 percent weight loss at 52 weeks, and phentermine-topiramate and liraglutide were associated with the highest odds of achieving at least 5 percent weight loss, according to a study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 14, 2016 Category: Science Source Type: news
Diabetes Drug Victoza May Help the Heart: Study
Daily, injected medication shows 'encouraging' results in international trial
Source: HealthDay
Related MedlinePlus Pages: Diabetes Medicines, Heart Attack, Stroke (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - June 14, 2016 Category: Consumer Health News Source Type: news
Diabetes Drug Victoza May Help the Heart: Study
TUESDAY, June 14, 2016 -- The blood sugar-lowering drug Victoza (liraglutide) cuts the risk of heart attack and stroke in type 2 diabetes patients, a new study finds.
Heart disease is the leading cause of death among people with type 2 diabetes, the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 14, 2016 Category: Journals (General) Source Type: news
Novo diabetes drug cuts heart risks by less-than-hoped 13 percentage
(Reuters) - Novo Nordisk's top-selling diabetes drug Victoza cut the risk of heart attack, stroke and cardiovascular death by 13 percent in a closely watched study, but the result disappointed investors who had hoped for more. (Source: Reuters: Health)
Source: Reuters: Health - June 14, 2016 Category: Consumer Health News Tags: healthNews Source Type: news
